251 related articles for article (PubMed ID: 24499991)
21. [Peroral hormonal contraception and risk of venous thromboembolism].
Ludka O; Spinar J; Musil V; Pozdísek Z
Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort.
Virkus RA; Løkkegaard E; Lidegaard Ø; Langhoff-Roos J; Nielsen AK; Rothman KJ; Bergholt T
PLoS One; 2014; 9(5):e96495. PubMed ID: 24788753
[TBL] [Abstract][Full Text] [Related]
23. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
Kurvits K; Laius O; Uusküla M; Laanpere M
Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
[TBL] [Abstract][Full Text] [Related]
24. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
[TBL] [Abstract][Full Text] [Related]
25. [Which contraception for women with increased risk of venous thromboembolism?].
Julen O; Dubuisson JB; Lourenço AG
Rev Med Suisse; 2011 Feb; 7(281):351-4, 356. PubMed ID: 21416714
[TBL] [Abstract][Full Text] [Related]
26. Symptomatic Venous Thromboembolism After Achilles Tendon Rupture: A Nationwide Danish Cohort Study of 28,546 Patients With Achilles Tendon Rupture.
Pedersen MH; Wahlsten LR; Grønborg H; Gislason GH; Petersen MM; Bonde AN
Am J Sports Med; 2019 Nov; 47(13):3229-3237. PubMed ID: 31574237
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.
Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G
Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982
[No Abstract] [Full Text] [Related]
28. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.
Vaillant-Roussel H; Ouchchane L; Dauphin C; Philippe P; Ruivard M
Contraception; 2011 Nov; 84(5):e23-30. PubMed ID: 22018134
[TBL] [Abstract][Full Text] [Related]
29. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
Raymond EG; Burke AE; Espey E
Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Tirado R; Cañas I; Riera A; Valdés M; Monreal M;
Thromb Haemost; 2009 Mar; 101(3):478-82. PubMed ID: 19277408
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism in women: a specific reproductive health risk.
ESHRE Capri Workshop Group
Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
[TBL] [Abstract][Full Text] [Related]
32. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
[TBL] [Abstract][Full Text] [Related]
33. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
;
Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
[TBL] [Abstract][Full Text] [Related]
34. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
35. Contraception-related venous thromboembolism in a pediatric institution.
Pillai P; Bonny AE; O'Brien SH
J Pediatr Adolesc Gynecol; 2013 Jun; 26(3):186-8. PubMed ID: 23566795
[TBL] [Abstract][Full Text] [Related]
36. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
Fruzzetti F; Perini D; Spirito N; Manca R
Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005.
Kane EV; Calderwood C; Dobbie R; Morris C; Roman E; Greer IA
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):223-9. PubMed ID: 23684606
[TBL] [Abstract][Full Text] [Related]
38. Critique of a Danish cohort study on hormonal contraception and VTE.
Lidegaard O
J Fam Plann Reprod Health Care; 2010 Apr; 36(2):103-4; author reply 104-5. PubMed ID: 20406557
[No Abstract] [Full Text] [Related]
39. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
[TBL] [Abstract][Full Text] [Related]
40. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
